Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LASA.NSthis companyLasa Supergenerics Limited	₹4.22	-0.83×	0.57×	1.13×	-1.34×	-306.6%	-27.4%	-53.2%	-135.6%	-68.7%	-22.1%	0.0%	0.2×	-0.34×	-34.66×	0.62×	0.0%	2	—	2	C
BACPHAR.BOBacil Pharma Limited	₹16.82	43×	2.7×	0×	-270.7×	-93.7%	0.0%	0.0%	0.0%	6.3%	-1.0%	1.1%	0×	2.32×	0×	0.68×	0.0%	2	2.81	3	B-
BALAXI.NSBalaxi Pharmaceuticals Limited	₹22.66	60.27×	0.34×	0.31×	17.26×	-101.9%	41.7%	1.9%	0.5%	0.6%	0.4%	-52.9%	0.23×	5.79×	1.36×	4.51×	0.0%	5	2.08	1	D+
BIBIOFILCHEM.BOBiofil Chemicals and Pharmaceuticals Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BIOFILCHEM.NSBiofil Chemicals and Pharmaceuticals Limited	₹30.51	15.08×	1.95×	1.48×	11.18×	-30.6%	3.7%	1.3%	9.8%	12.9%	1.2%	-1.9%	0.14×	-0.08×	37.37×	1.73×	0.0%	4	—	1	C-
CHOKSI.BOChoksi Asia Limited	₹202.95	12.92×	1.64×	1.4×	9.46×	-1881.5%	17.9%	13.2%	10.8%	12.7%	10.4%	-0.2%	0.05×	-0.68×	15.37×	6.67×	0.0%	4	15.2	1	C-
Peer median	—	29.04×	1.79×	0.86×	10.32×	-97.8%	10.8%	1.6%	5.2%	9.5%	0.8%	-1.1%	0.09×	1.12×	8.36×	3.12×	0.0%	4	2.81	1	—